Amphastar Pharma (AMPH) Stock Price, Quote, News & History | Benzinga

SPY778.57+0.60%QQQ751.38+0.51%BTC/USD83,008.30+0.10%DIA516.21+0.89%GLD384.50+1.55%TLT77.97+0.12%

Amphastar Pharmaceuticals Inc (AMPH) Stock Price, Quote, News & History

AMPHNASDAQ

Trade with Public

Trade with Public

$26.62

0.813.14%

Last update: Oct 9, 4:00 PM

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$25.73

Close

$26.62

Volume / Avg.

263.48K / 471.45K

Day Range

$26.62 - $26.62

52 Wk Range

16.65 - 29.52

Market Cap

$1.10B

P/E Ratio

15.28

Dividend Yield

-

Exchange

NASDAQ

RSI

66

Short Interest

22.57%

Days to Cover

7.1

Recent Amphastar Pharmaceuticals, Inc. News

Two Years to Build or Pay 200% — Which US Pharma Stocks Win?

Trump sets a 2-year ultimatum for generic drugmakers to reshore U.S. production or face tariffs up to 200%.

Stjepan Kalinic

Crude Oil Gains 2%; Comcast Shares Spike Higher

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 200 points on Monday. The Dow traded up 0.44% to 52,105.66 while the NASDAQ rose 1.33% to 25,634.54. The S&P 500 also

Avi Kapoor

This Liquidia Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Top Wall Street analysts changed outlook on top stocks. See all changes including upgrades, downgrades, and initiations on analyst ratings page.

Avi Kapoor

This Whirlpool Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Analysts downgraded DOCS, MWH, WHR, AMPH, and WIX and lowered price targets. See how analysts view these stocks. Considering WHR stock? See analyst opinions.

Avi Kapoor

This HubSpot Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday

Wall Street analysts changed outlook on top names. Check all changes on analyst ratings page. See what analysts think about HUBS stock.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

184.61M

Investing Cash Flow (TTM)

-52.05M

Financing Cash Flow (TTM)

-96.46M

Free Cash Flow (TTM)

152.89M

Capital Expenditure (TTM)

-31.72M

Net Change in Cash (TTM)

36.10M

Analyst Trends and Forecast

0

0

0

0

Apr

2

May

1

1

Jun

3

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.3

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.53B

PE Ratio (TTM)

15.28

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

1.64

PB Ratio (TTM)

1.43

Earnings Yield % (TTM)

6.54%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

7.76

Price / EBITDA (TTM)

6.21

Price / Free Cash Flow (TTM)

7.84

Book Value / Share

$18.06

Company Debt

Total Debt

$612.05M

LT Debt

$609.56M

LT Debt Issuance (TTM)

$445.00K

LT Debt Repayment (TTM)

-$702.00K

Total Cash

$223.61M

Debt to Equity

0.90

Issuance of Debt (TTM)

-$257.00K

Repayment of Debt (TTM)

-$702.00K